Search

Find a vulnerability

Search criteria ⓘ Use this form to refine search results.
Full-text search supports keyword queries with ranking and filtering.
You can combine vendor, product, and sources to narrow results.
Enable “Apply ordering” to sort by date instead of relevance.

    2 vulnerabilities by Apollo Pharmacy

    CVE-2026-50034 (GCVE-0-2026-50034)

    Vulnerability from cvelistv5 – Published: 2026-06-18 23:47 – Updated: 2026-06-18 23:47
    VLAI
    Title
    Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Cleartext Transmission of Sensitive Information
    Summary
    An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.
    Severity
    6.5 (Medium)
    CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
    7.1 (High)
    CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N
    CWE
    Assigner
    References
    Impacted products
    Credits
    Rishitha Pucchakayala and Centre for Development of Advanced Computing (Hyderabad) reported these vulnerabilities to CISA.
    Show details on NVD website
    To clipboard 

    {
  "containers": {
    "cna": {
      "affected": [
        {
          "defaultStatus": "unaffected",
          "product": "Blood Glucose Monitoring System (Model No. APG-01 BT)",
          "vendor": "Apollo Pharmacy",
          "versions": [
            {
              "status": "affected",
              "version": "0x0110_v1.1.0"
            }
          ]
        }
      ],
      "credits": [
        {
          "lang": "en",
          "type": "finder",
          "value": "Rishitha Pucchakayala and Centre for Development of Advanced Computing (Hyderabad) reported these vulnerabilities to CISA."
        }
      ],
      "descriptions": [
        {
          "lang": "en",
          "supportingMedia": [
            {
              "base64": false,
              "type": "text/html",
              "value": "An attacker within BLE communication range can passively intercept \nwireless traffic and obtain sensitive health-related information, \nincluding glucose measurement values."
            }
          ],
          "value": "An attacker within BLE communication range can passively intercept \nwireless traffic and obtain sensitive health-related information, \nincluding glucose measurement values."
        }
      ],
      "metrics": [
        {
          "cvssV3_1": {
            "attackComplexity": "LOW",
            "attackVector": "ADJACENT_NETWORK",
            "availabilityImpact": "NONE",
            "baseScore": 6.5,
            "baseSeverity": "MEDIUM",
            "confidentialityImpact": "HIGH",
            "integrityImpact": "NONE",
            "privilegesRequired": "NONE",
            "scope": "UNCHANGED",
            "userInteraction": "NONE",
            "vectorString": "CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N",
            "version": "3.1"
          },
          "format": "CVSS",
          "scenarios": [
            {
              "lang": "en",
              "value": "GENERAL"
            }
          ]
        },
        {
          "cvssV4_0": {
            "Automatable": "NOT_DEFINED",
            "Recovery": "NOT_DEFINED",
            "Safety": "NOT_DEFINED",
            "attackComplexity": "LOW",
            "attackRequirements": "NONE",
            "attackVector": "ADJACENT",
            "baseScore": 7.1,
            "baseSeverity": "HIGH",
            "exploitMaturity": "NOT_DEFINED",
            "privilegesRequired": "NONE",
            "providerUrgency": "NOT_DEFINED",
            "subAvailabilityImpact": "NONE",
            "subConfidentialityImpact": "NONE",
            "subIntegrityImpact": "NONE",
            "userInteraction": "NONE",
            "valueDensity": "NOT_DEFINED",
            "vectorString": "CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N",
            "version": "4.0",
            "vulnAvailabilityImpact": "NONE",
            "vulnConfidentialityImpact": "HIGH",
            "vulnIntegrityImpact": "NONE",
            "vulnerabilityResponseEffort": "NOT_DEFINED"
          },
          "format": "CVSS",
          "scenarios": [
            {
              "lang": "en",
              "value": "GENERAL"
            }
          ]
        }
      ],
      "problemTypes": [
        {
          "descriptions": [
            {
              "cweId": "CWE-319",
              "description": "CWE-319",
              "lang": "en",
              "type": "CWE"
            }
          ]
        }
      ],
      "providerMetadata": {
        "dateUpdated": "2026-06-18T23:47:13.970Z",
        "orgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
        "shortName": "icscert"
      },
      "references": [
        {
          "url": "https://www.apollopharmacy.in/contact-us"
        },
        {
          "url": "https://www.cisa.gov/news-events/news/understanding-bluetooth-technology"
        },
        {
          "url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01"
        },
        {
          "url": "https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json"
        }
      ],
      "source": {
        "advisory": "ICSMA-26-169-01",
        "discovery": "EXTERNAL"
      },
      "title": "Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Cleartext Transmission of Sensitive Information",
      "workarounds": [
        {
          "lang": "en",
          "supportingMedia": [
            {
              "base64": false,
              "type": "text/html",
              "value": "\u003cp\u003eApollo Pharmacy did not respond to CISA\u0027s requests to coordinate. \nUsers are encouraged to reach out to Apollo Pharmacy directly for more \ninformation:\u003cbr\u003e\u003ca href=\"https://www.apollopharmacy.in/contact-us\"\u003ehttps://www.apollopharmacy.in/contact-us\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003cbr\u003eCISA recommends users follow the \nguidance in the Understanding Bluetooth Technology blog:\u0026nbsp;\u003cbr\u003e\u003ca href=\"https://www.cisa.gov/news-events/news/understanding-bluetooth-technology\"\u003ehttps://www.cisa.gov/news-events/news/understanding-bluetooth-technology\u003c/a\u003e\u003c/p\u003e"
            }
          ],
          "value": "Apollo Pharmacy did not respond to CISA\u0027s requests to coordinate. \nUsers are encouraged to reach out to Apollo Pharmacy directly for more \ninformation:\n https://www.apollopharmacy.in/contact-us \n\n\n\n\n\nCISA recommends users follow the \nguidance in the Understanding Bluetooth Technology blog:\u00a0\n https://www.cisa.gov/news-events/news/understanding-bluetooth-technology"
        }
      ],
      "x_generator": {
        "engine": "Vulnogram 1.0.2"
      }
    }
  },
  "cveMetadata": {
    "assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
    "assignerShortName": "icscert",
    "cveId": "CVE-2026-50034",
    "datePublished": "2026-06-18T23:47:13.970Z",
    "dateReserved": "2026-06-10T21:21:12.237Z",
    "dateUpdated": "2026-06-18T23:47:13.970Z",
    "state": "PUBLISHED"
  },
  "dataType": "CVE_RECORD",
  "dataVersion": "5.2"
}

    CVE-2026-52866 (GCVE-0-2026-52866)

    Vulnerability from cvelistv5 – Published: 2026-06-18 23:45 – Updated: 2026-06-18 23:45
    VLAI
    Title
    Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Missing Authorization
    Summary
    An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection.
    Severity
    6.5 (Medium)
    CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
    7.1 (High)
    CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N
    CWE
    Assigner
    References
    Impacted products
    Credits
    Rishitha Pucchakayala and Centre for Development of Advanced Computing (Hyderabad) reported these vulnerabilities to CISA.
    Show details on NVD website
    To clipboard 

    {
  "containers": {
    "cna": {
      "affected": [
        {
          "defaultStatus": "unaffected",
          "product": "Blood Glucose Monitoring System (Model No. APG-01 BT)",
          "vendor": "Apollo Pharmacy",
          "versions": [
            {
              "status": "affected",
              "version": "0x0110_v1.1.0"
            }
          ]
        }
      ],
      "credits": [
        {
          "lang": "en",
          "type": "finder",
          "value": "Rishitha Pucchakayala and Centre for Development of Advanced Computing (Hyderabad) reported these vulnerabilities to CISA."
        }
      ],
      "descriptions": [
        {
          "lang": "en",
          "supportingMedia": [
            {
              "base64": false,
              "type": "text/html",
              "value": "An attacker within BLE communication range can monopolize the device\u0027s \nonly available BLE connection slot, preventing legitimate users or \napplications from establishing a connection."
            }
          ],
          "value": "An attacker within BLE communication range can monopolize the device\u0027s \nonly available BLE connection slot, preventing legitimate users or \napplications from establishing a connection."
        }
      ],
      "metrics": [
        {
          "cvssV3_1": {
            "attackComplexity": "LOW",
            "attackVector": "ADJACENT_NETWORK",
            "availabilityImpact": "HIGH",
            "baseScore": 6.5,
            "baseSeverity": "MEDIUM",
            "confidentialityImpact": "NONE",
            "integrityImpact": "NONE",
            "privilegesRequired": "NONE",
            "scope": "UNCHANGED",
            "userInteraction": "NONE",
            "vectorString": "CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H",
            "version": "3.1"
          },
          "format": "CVSS",
          "scenarios": [
            {
              "lang": "en",
              "value": "GENERAL"
            }
          ]
        },
        {
          "cvssV4_0": {
            "Automatable": "NOT_DEFINED",
            "Recovery": "NOT_DEFINED",
            "Safety": "NOT_DEFINED",
            "attackComplexity": "LOW",
            "attackRequirements": "NONE",
            "attackVector": "ADJACENT",
            "baseScore": 7.1,
            "baseSeverity": "HIGH",
            "exploitMaturity": "NOT_DEFINED",
            "privilegesRequired": "NONE",
            "providerUrgency": "NOT_DEFINED",
            "subAvailabilityImpact": "NONE",
            "subConfidentialityImpact": "NONE",
            "subIntegrityImpact": "NONE",
            "userInteraction": "NONE",
            "valueDensity": "NOT_DEFINED",
            "vectorString": "CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N",
            "version": "4.0",
            "vulnAvailabilityImpact": "HIGH",
            "vulnConfidentialityImpact": "NONE",
            "vulnIntegrityImpact": "NONE",
            "vulnerabilityResponseEffort": "NOT_DEFINED"
          },
          "format": "CVSS",
          "scenarios": [
            {
              "lang": "en",
              "value": "GENERAL"
            }
          ]
        }
      ],
      "problemTypes": [
        {
          "descriptions": [
            {
              "cweId": "CWE-862",
              "description": "CWE-862",
              "lang": "en",
              "type": "CWE"
            }
          ]
        }
      ],
      "providerMetadata": {
        "dateUpdated": "2026-06-18T23:45:34.263Z",
        "orgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
        "shortName": "icscert"
      },
      "references": [
        {
          "url": "https://www.apollopharmacy.in/contact-us"
        },
        {
          "url": "https://www.cisa.gov/news-events/news/understanding-bluetooth-technology"
        },
        {
          "url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01"
        },
        {
          "url": "https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json"
        }
      ],
      "source": {
        "advisory": "ICSMA-26-169-01",
        "discovery": "EXTERNAL"
      },
      "title": "Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Missing Authorization",
      "workarounds": [
        {
          "lang": "en",
          "supportingMedia": [
            {
              "base64": false,
              "type": "text/html",
              "value": "\u003cp\u003eApollo Pharmacy did not respond to CISA\u0027s requests to coordinate. \nUsers are encouraged to reach out to Apollo Pharmacy directly for more \ninformation:\u003cbr\u003e\u003ca href=\"https://www.apollopharmacy.in/contact-us\"\u003ehttps://www.apollopharmacy.in/contact-us\u003c/a\u003e\u003c/p\u003e\n\u003cp\u003e\u003cbr\u003eCISA recommends users follow the \nguidance in the Understanding Bluetooth Technology blog:\u0026nbsp;\u003cbr\u003e\u003ca href=\"https://www.cisa.gov/news-events/news/understanding-bluetooth-technology\"\u003ehttps://www.cisa.gov/news-events/news/understanding-bluetooth-technology\u003c/a\u003e\u003c/p\u003e"
            }
          ],
          "value": "Apollo Pharmacy did not respond to CISA\u0027s requests to coordinate. \nUsers are encouraged to reach out to Apollo Pharmacy directly for more \ninformation:\n https://www.apollopharmacy.in/contact-us \n\n\n\n\n\nCISA recommends users follow the \nguidance in the Understanding Bluetooth Technology blog:\u00a0\n https://www.cisa.gov/news-events/news/understanding-bluetooth-technology"
        }
      ],
      "x_generator": {
        "engine": "Vulnogram 1.0.2"
      }
    }
  },
  "cveMetadata": {
    "assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
    "assignerShortName": "icscert",
    "cveId": "CVE-2026-52866",
    "datePublished": "2026-06-18T23:45:34.263Z",
    "dateReserved": "2026-06-10T21:21:12.261Z",
    "dateUpdated": "2026-06-18T23:45:34.263Z",
    "state": "PUBLISHED"
  },
  "dataType": "CVE_RECORD",
  "dataVersion": "5.2"
}